Clinical trials sponsored by Sinotau Pharmaceutical Group

Phase breakdown

Conditions studied

Recruiting trials led by Sinotau Pharmaceutical Group

• A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults
  NCT07149831 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
  NCT07115238 · Phase: Phase 3 · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer
  NCT07115277 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials is Sinotau Pharmaceutical Group recruiting for?

Sinotau Pharmaceutical Group is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.